Wednesday, July 8, 2026

Drug profile · INN

fluoxymesterone

fluoxymesterone (FLUOXYMESTERONE) is a androgen receptor agonist. Route of administration: oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — fluoxymesterone
US status
approved
Class
Route
ORAL
Patents
0
Programs
1
Data quality
0.84

Quick answer

fluoxymesterone (FLUOXYMESTERONE) is a androgen receptor agonist. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN fluoxymesterone
Brand FLUOXYMESTERONE
Mechanism Androgen Receptor agonist
Target Androgen receptor
Route ORAL
Formulation TABLET

Mechanism of action

Androgen Receptor agonist

Primary target: Androgen receptor

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. Intravitreal Aflibercept Injection Phase 2 · Regeneron UK · Central Retinal Vein Occlusion

Related & competitor drugs

  1. bicalutamide Androgen Receptor antagonist
  2. danazol Progesterone receptor agonist
  3. nandrolone decanoate Androgen Receptor agonist
  4. testosterone Genito-urinary system and sex hormones (G03)
  5. testosterone cypionate Androgen Receptor agonist
  6. apalutamide Antineoplastic and immunomodulating agents (L02)

Frequently asked questions

What is fluoxymesterone?

fluoxymesterone (FLUOXYMESTERONE) is a androgen receptor agonist. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for fluoxymesterone?

FLUOXYMESTERONE is a marketed brand name for fluoxymesterone. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of fluoxymesterone?

fluoxymesterone has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.